NDC 63629-3383
Namenda
Memantine Hydrochloride
Namenda is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Memantine Hydrochloride.
| Product ID | 63629-3383_650922c0-282d-489d-8718-4c9c001d0ac4 |
| NDC | 63629-3383 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Namenda |
| Generic Name | Memantine Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-10-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021487 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | MEMANTINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 63629-3383-4
180 TABLET in 1 BOTTLE (63629-3383-4)
| Marketing Start Date | 2003-10-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63629-3383-2 [63629338302]
Namenda TABLET
| Marketing Category | NDA |
| Application Number | NDA021487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-27 |
| Marketing End Date | 2008-03-01 |
NDC 63629-3383-3 [63629338303]
Namenda TABLET
| Marketing Category | NDA |
| Application Number | NDA021487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-27 |
| Marketing End Date | 2008-03-01 |
NDC 63629-3383-1 [63629338301]
Namenda TABLET
| Marketing Category | NDA |
| Application Number | NDA021487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-27 |
| Marketing End Date | 2008-03-01 |
NDC 63629-3383-4 [63629338304]
Namenda TABLET
| Marketing Category | NDA |
| Application Number | NDA021487 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-27 |
| Marketing End Date | 2008-03-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| MEMANTINE HYDROCHLORIDE | 5 mg/1 |
OpenFDA Data
| SPL SET ID: | bd8fa299-b5ff-4387-b4b2-40adfecaa8f6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- NMDA Receptor Antagonists [MoA]
- N-methyl-D-aspartate Receptor Antagonist [EPC]
NDC Crossover Matching brand name "Namenda" or generic name "Memantine Hydrochloride"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0456-3200 | Namenda | Memantine Hydrochloride |
| 0456-3205 | Namenda | memantine hydrochloride |
| 0456-3210 | Namenda | memantine hydrochloride |
| 0456-3400 | Namenda | memantine hydrochloride |
| 0456-3407 | Namenda | memantine hydrochloride |
| 0456-3414 | Namenda | memantine hydrochloride |
| 0456-3421 | Namenda | memantine hydrochloride |
| 0456-3428 | Namenda | memantine hydrochloride |
| 21695-169 | Namenda | Namenda |
| 21695-232 | Namenda | Namenda |
| 55289-937 | Namenda | Namenda |
| 55154-4617 | Namenda | Namenda |
| 63629-3383 | Namenda | Namenda |
| 63629-5291 | Namenda | Namenda |
| 67046-489 | Namenda | Namenda |
| 0121-0850 | Memantine Hydrochloride | Memantine Hydrochloride |
| 0527-1221 | Memantine Hydrochloride | Memantine Hydrochloride |
| 0527-1222 | Memantine Hydrochloride | Memantine Hydrochloride |
| 0527-1943 | Memantine Hydrochloride | Memantine Hydrochloride |
| 0591-3011 | memantine hydrochloride | memantine hydrochloride |
| 0591-3870 | memantine hydrochloride | memantine hydrochloride |
Trademark Results [Namenda]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NAMENDA 78093238 2843824 Live/Registered |
MERZ PHARMA GMBH & CO. KGAA 2001-11-14 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.